New magnetic bimetallic yanus-like Ag-Fe nanoparticles for antitumine therapy

The purpose of the study was to analyze the antitumor activity of magnetic bimetallic Ag-Fe nanoparticles having the structure of Yanus particles produced by the electrical explosion of wires. material and methods. For the synthesis of bimetallic Ag-Fe nanoparticles, a simultaneous electric explosion of silver and iron wires in an argon atmosphere was used. The morphology and size of the nanoparticles and their agglomerates were determined by transmission electron microscopy. To determine the average size of nanoparticles, particle size distribution histograms approximated by log-normal distribution were plotted. The phase composition was determined using x-ray method. The cytotoxic effect of the nanoparticles was evaluated by MTT assay using mouse neuro-2a (N2a) neuroblastoma cell lines and J774 histiocytic sarcoma cell lines. results. In case of simultaneous electric explosion of silver and iron wires in an argon atmosphere, the spherical 72 nm particles were obtained. Silver and iron were shown to be unevenly distributed in particles. There were areas enriched with one of the components with clear boundaries of phase separation or Janus nanoparticles. On the diffractogram of the sample, the main reflections correspond to the phases of metallic Ag and Fe. Aqueous suspensions of monometallic Ag and Fe nanoparticles reduced cell viability to a lesser extent than bimetallic nanoparticles. Ag-Fe nanoparticles showed the highest dose-dependent antitumor activity. The higher corrosion rate of bimetallic Ag-Fe particles compared to monometallic nanoparticles was due to the larger contact area between metallic phases in Janus nanoparticles, which determined a larger number of corrosion centers in bimetallic nanoparticles. conclusion. As a result of an electric explosion of wires from immiscible metals of iron and silver, bimetallic Ag-Fe nanoparticles with Janus particle structure were obtained. Ag-Fe nanoparticles exhibite higher antitumor activity than the individual metals from which they are composed and are a promising material for the fight against cancer cells.

electric explosion of wires, Janus nanoparticles, segregated structure, mtt assay, mtt-test, iron metals, silver metals, electron microscopy, biocompatibility, synthesized nanoparticles

1. Witte K., Müller K., Grüttner C., Westphal F., Johansson C. Particle size‐ and concentration‐dependent separation of magnetic nanoparticles. J Magnetism Magnetic Materials. 2017 Apr; 427 (1): 320–324. doi: 10.1016/j.jmmm.2016.11.006.

2. Sensenig R., Sapir Y., MacDonald C., Cohen S., Polyak B. Magnetic nanoparticle‐based approaches to locally target therapy and enhance tissue regeneration in vivo. Nanomedicine (Lond). 2012 Sep; 7 (9): 1425–1442. doi: 10.2217/nnm.12.109.

3. Estelrich J., Sánchez-Martín M.J., Busquets M.A. Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents. Int J Nanomedicine. 2015 Mar 6; 10: 1727–41. doi: 10.2147/IJN.S76501.

4. Kayal S., Ramanujan R.V. Anti‐Cancer Drug Loaded Iron–Gold Core–Shell Nanoparticles (Fe@Au) for Magnetic Drug Targeting. J Na‐ nosci Nanotechnol. 2010 Sep; 10 (9): 5527–39.

5. Medici S., Peana M., Crisponi G., Nurchi V.M., Lachowicz J.I., Remelli M., Zoroddu M.A. Silver coordination compounds: A new hori‐ zon in medicine. Coord Chem Rev. 2016 Nov; 327–328: 349–359. doi: 10.1016/j.ccr.2016.05.015.

6. Drake P.L., Hazelwood K.J. Exposure‐related health effects of silver and silver compounds: A review. Ann Occup Hyg. 2005; 49: 575–585. doi: 10.1093/annhyg/mei019.

7. Medvetz D.A., Hindi K.M., Panzner M.J., Ditto A.J., Yun Y.H., Youngs W.J. Anticancer Activity of Ag(I) N‐Heterocyclic Carbene Com‐ plexes Derived from 4,5‐Dichloro‐1H‐Imidazole. Met Based Drugs. 2008; 2008: 384010. doi: 10.1155/2008/384010.

8. Franco-Molina M.A., Mendoza-Gamboa E., Sierra-Rivera C.A., Gómez-Flores R.A., Zapata-Benavides P., Castillo-Tello P., Alcocer-González J.M., Miranda-Hernández D.F., Tamez-Guerra R.S., Rodríguez- Padilla C. Antitumor activity of colloidal silver on MCF‐7 human breast cancer cells. J Exp Clin Cancer Res. 2010 Nov 16; 29: 148. doi: 10.1186/1756‐9966‐29‐148.

9. Johnson N.A., Southerland M.R., Youngs W.J. Developments in the Medicinal Applications of Silver‐NHC Complexes and Imidazolium Salts. Molecules. 2017 Jul 27; 22 (8). pii: E1263. doi: 10.3390/mol‐ ecules22081263.

10. Rosman R., Saifullah B., Maniam S., Dorniani D., Hussein M.Z., Fakurazi S. Improved Anticancer Effect of Magnetite Nanocomposite Formulation of GALLIC Acid (Fe3O4‐PEG‐GA) Against Lung, Breast and Colon Cancer Cells. Nanomaterials (Basel). 2018 Feb 2; 8 (2). pii: E83. doi: 10.3390/nano8020083.

11. Lerner M.I., Pervikov A.V., Glazkova E.A., Svarovskaya N.V., Lozhkomoev A.S., Psakhie S.G. Structures of binary metallic nanopar‐ ticles produced by electrical explosion of two wires from immiscible elements. Powder Technology. 2016; 288: 371–378. doi: 10.1016/j. powtec.2015.11.037.

12. Thoidingjam S., Tiku A.B. New developments in breast cancer therapy: role of iron oxide nanoparticles. Advances in Natural Sciences: Nanoscience and Nanotechnology. 2017. 8: 023002. doi: 10.1088/2043‐ 6254/aa5e33.

13. Patil R.M., Thorat N.D., Shete P.B., Bedge P.A., Gavde S., Joshi M.G., Tofail S.A.M., Bohara R.A. Comprehensive cytotoxicity studies of super‐ paramagnetic iron oxide nanoparticles. Biochem Biophys Rep. 2018 Jan 8; 13: 63–72. doi: 10.1016/j.bbrep.2017.12.002.